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Objective: There are very few studies on laparoscopic adjustable gastric banding (LAGB) in 
obese adolescents with follow up for more than 36 months, let alone good prospective data 
beyond 24 months in Australian adolescents. We aimed to evaluate medium term (>36 months) 
safety and efficacy of LAGB in adolescents with severe obesity. 
Methods: Prospective cohort study (March 2009–December 2015) in one tertiary referral 
hospital including obese adolescents (14-18 years) with a body mass index (BMI) >40 (or ≥35 
with comorbidities) who consented to have LAGB. Exclusion criteria were syndromal causes 
of obesity, depression and oesophageal motility disorders.  Main outcome measures include 
change in weight and BMI at 6, 12, 24, 36 and 48 months post LAGB. Postoperative 
complications and admissions. 
Results: 21 adolescents (median [Interquartile range (IQR)] 17.4 [16.5-17.7] years, 9 males, 
mean ± SD BMI 47.3 ± 8.4 kg/m2) had a median follow up of 45.5 [32-50] months post LAGB. 
Follow up data were available for 16 adolescents. Weight and BMI improved significantly at 
all follow up times (all p <0.01). The median maximum BMI loss was 10 [7.1-14.7] kg/m2. 
There were 4 minor early complications. Seven bands were removed due to weight loss 
failure/regain (2 had also obstructive symptoms).  
Conclusions: We have shown in the longest prospective LAGB postoperative follow up study 
of Australian adolescents, that LAGB improves BMI in the majority of adolescents without 
significant comorbidities. LAGB is still a reasonable option to be considered as a temporary 
procedure to manage severe obesity during adolescence. 






The obesity epidemic is a global phenomenon [1].  In Australia 25% of children aged 6 to18 
years have been identified as either overweight or obese and around 5% as obese [2]. Childhood 
obesity is linked to serious physical, psychologic and social comorbidities, and may result in 
reduced life expectancy due to early onset of disorders such as type 2 diabetes, hypertension, 
non-alcoholic steatohepatitis, obstructive sleep apnoea, depression accompanied by anxiety 
and low self-esteem. These comorbidities are becoming more prevalent in adolescents and 
young adults [3,4].  
A multidisciplinary approach underpins obesity treatment and can result in improvement in 
weight and comorbidities. This approach includes lifestyle interventions such as dietary 
modification, increased physical activity, reduced sedentary activity, behaviour modification, 
family therapy and targeted medications [5,6]. Meta-analyses have shown that non-
pharmacological and pharmacological management strategies evaluated in adolescents over a 
period of 6 to 12 months are only mildly effective in reducing body mass index (BMI) [5]. For 
example behavioural interventions reduce BMI by 3 kg/m2 [5] and metformin reduces BMI by 
1 kg/m2 [7]. As opposed to these therapies it has become apparent that bariatric surgery is the 
most effective treatment for obese adults [8] and recent studies including a meta-analysis 
indicate similar benefits can be expected in adolescents in the short term [9–14]. According to 
Australian and New Zealand recommendations and revised National Health and Medical 
Research Council guidelines for obesity management laparoscopic adjustable gastric banding 
(LAGB) should be considered in post-pubertal adolescents with a BMI > 40 kg/m2 or BMI ≥ 
35 kg/m2 with obesity-related comorbidities [6,15].  
A recent meta-analysis of bariatric surgical procedures including mostly short term follow up 
studies in 538 adolescents undergoing LAGB reported a BMI loss of 11 kg/m2, improvement 
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of comorbidities, no deaths and minor complications [12]. Medium to long-term studies (more 
than 36 months post-surgery) regarding the efficacy of LAGB in adolescents are scarce [16] 
and there is no prospective data beyond 24 months in Australian adolescents [13,17,18]. 
Therefore, we aimed to evaluate longitudinally safety and medium term effects of LAGB in 
severely obese adolescents in the South Australian Health Service.  
 
Materials and Methods 
 
Design and Subjects  
This prospective single centre observational study (March 2009–December 2015) was 
designed to determine the efficacy and safety of LAGB in adolescents. The study was approved 
by the Hospital Research Ethics Committee (HREC 2168/5/15). Written informed consent was 
obtained from all parents of participants and written assent from all participants. 
Adolescents who were referred by paediatricians for LAGB assessment to a single Paediatric 
Surgeon from March 2009 until May 2013 were recruited consecutively after they were 
considered eligible for LAGB. Inclusion criteria for LAGB were age 14 to 18 years with a BMI 
40 or 35 with co-morbidities, Tanner pubertal development stage 4, and documented failure of 
medical management over 6 months. Inclusion criteria for the study were consent for the LAGB 
procedure as well as physiological oesophageal and gastric studies prior to LAGB and 6 months 
post LAGB (Data on these studies were not included in this manuscript). Exclusion criteria for 
the study were syndromal causes of obesity, depression and oesophageal motility disorders.   
All adolescents received preoperative multidisciplinary evaluation from a paediatrician, 
paediatric surgeon, dietitian and psychologist, and were advised to consider LAGB as an 
interim measure. The rationale behind this advice was that as a constricting foreign body, the 
chances of band related complications such as erosion, reflux, esophageal dismotility disorder, 
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pouch dilation or slippage would increase with longer time exposure. Preoperative 
psychological evaluation included two reviews to screen for depression, underlying motivation 
and to ensure there was adequate comprehension of LAGB procedure.  
Surgical Technique 
All procedures were performed laparoscopically by a single paediatric surgeon mentored by 2 
experienced bariatric surgeons. All adolescents were operated on after 4 weeks of exclusive 
preoperative very low calorie diet (Optifast® VLCD™, Nestlé, Switzerland).  The pars flaccida 
technique with the insertion of the Swedish Adjustable Gastric Band (SAGB-VC, Ethicon INC, 
Somerville, USA) was used in all adolescents. Two to three anterior gastro-gastric serosa-to-
serosa sutures using non-absorbable Ethibond Excel® 2-0 (Ethicon INC, Somerville, USA) 
secured the band. The band was left empty without volume adjustment for at least 6 weeks 
postoperatively.  
Postoperative Management 
The fitness for discharge was determined by independent ambulation, pain well controlled on 
oral analgesia and travel time longer than 1 hour between home and hospital. The postoperative 
follow up protocol included monthly follow up for the first 6 months and then follow up was 
based on clinical progress with a review at least once a year. Missed visits did not necessary 
indicate withdrawal from the study as adolescents returned for later visits even after missing a 
previous visit. Subjects were not followed up after the gastric band was removed. Postoperative 
reviews by paediatric surgeon and dietitian included evaluation of food selection, weight, 
subjective assessment of band restriction, band fluid adjustments and postoperative 
complications. Band adjustments were driven primarily by clinical assessments of food intake 
restriction as reported by adolescents and the presence or absence of obstructive and/or reflux 
symptoms. Amount of weight loss was not taken into consideration for band adjustments. There 
was a relatively low threshold for consideration of band removal in keeping with the 
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preoperative advice. Transition to adult care was organised after a minimum of 3 years of 
follow up by a single paediatric surgeon. 
Outcome measures 
Outcome measures included changes in weight and BMI, development of early (< 30 days) and 
late (> 30 days) postoperative complications which were classified according to the Clavien - 
Dindo classification, [19] and presence of comorbidities. All admissions to hospital were 
documented over the follow up period.  
Weight was measured in light clothing using Wedderburn digital scales (Wedderburn, Sydney, 
Australia) at baseline, 6, 12, 24, 36 and 48 months post LAGB. Baseline measurements were 
defined as measurements obtained prior to Optifast. Height was measured on a wall stadiometer 
to the nearest 0.1 cm. BMI Z score was calculated using EpiInfo database version 3.5.1 
(www.cdc.gov/epiinfo). Maximum BMI loss was defined as the maximum BMI loss at any 
time point during the follow up. Health-related quality of life was assessed at baseline and 6 
month post LAGB using the Pediatric Quality of Life Inventory (PedsQL TM 4.0 MAPI, 
Research Institute, Lyon, France). Adolescents completed the Child Self-Report for ages 13 to 
18 years and their parents completed Parent Proxy-Report for ages 13 to 18 years. The PedsQL 
consists of 23 items describing physical, emotional, social and school performance aspects 
from which a total score is derived. Comorbidities evaluated pre and postoperative included 
presence of Type 2 diabetes using HbA1c and/or oral glucose tolerance test as diagnostic 
criteria, abnormal liver function defined as alanine transaminase (ALT) above the reference 
range; and at least one abnormality in fasting lipid profile including triglycerides, total 
cholesterol and/or LDL cholesterol above the reference range and HDL cholesterol below the 






Categorical data were summarized with the use of frequency of distributions. Continuous data 
were summarized as mean ± SD or median (interquartile range [IQR)]) according to normality. 
Comparison of weight and BMI changes was performed using the paired-samples Student’s t-
test. Statistical analyses were performed using MedCalc for Windows, version 12.5 (MedCalc 




Twenty nine adolescents were referred for assessment of LAGB in the South Australian Health 
Service. Eight adolescents did not participate in the study (7 did not have LAGB after surgical 
evaluation and 1 did not consent to be part of the study). 21 adolescents (9 males, 20 Caucasians 
and 1 Asian) with a median age of 17.3 (minimum 14.2 and maximum 18.2) years, a median 
[IQR] BMI of 47.1 [39.9-52.5] and a median [IQR] BMI z score of 2.7 [2.4-3.0] underwent 
LAGB between March 2009 and May 2013. 16 out of 21 adolescents had a BMI over 40 kg/m2. 
Preoperative comorbidities included: Pre-diabetes (n=2), high ALT (n=10), abnormal lipid 
profile (n=10), use of atorvastatin (n=1), use of continuous positive airway pressure for 
obstructive sleep apnoea (n=1) and hypertension on antihypertensive medication (n=1). None 
were taking antidepressants. The mean length of stay in hospital after LAGB was 2.8±0.6 days. 
Nine out of 21 adolescents improved in at least one comorbidity after LAGB. Two adolescents 
had resolution of their pre diabetes with normal glucose tolerance test and HbA1c below 5.7% 
post LAGB. ALT improved significantly after LAGB (Pre LAGB Median [IQR] of 39 [33.1-
68.9] U/L vs post LAGB Median [IQR] 21.5 [20.4-38.7] U/L, p=0.02). Mean ± SD overall 
quality of life scores improved significantly after 6 months as reported by both adolescents 
(60±20.5 vs 74.9±16.3, p=0.03) and parents (52.8±22.9 vs 74±16.3, p=0.02).  
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Multiple phone calls and appointments with phone calls and short message service reminders 
were made to optimize follow up of adolescents, one of which moved overseas. Complete 
follow up data for weight over the study period was available for 16/21 adolescents (76%). 
Three adolescents did not come back post LAGB (2 after 12 months, 1 after 18 months), but 
phone contact with families and new treating private adult bariatric surgeon confirmed their 
bands were still in situ. Two adolescents who missed the 48 months follow up visit came at 60 
months.  
Weight and BMI loss changes  
Pre and postoperative BMI for each individual during the study period is included in Table 1. 
Median [IQR] BMI at last follow up was 39.2 [31.7-50.3] kg/m2 after a median follow up 45.5 
[32-50] months. Median [IQR] post LAGB maximum BMI loss was 10 [7.0-14.6] kg/m2 after 
a median follow up of 13 [6- 41.2] months. Weight and BMI changes over time including 
number of available/eligible adolescents at every time point are included in Table 2. In uni-
variable generalized estimating equation models, BMI post LAGB at all time follow up visits 
(3, 6, 12, 24, 36 and 48 months) improved significantly compared to BMI pre LAGB (all 
p<0.001).  
Early and late postoperative complications  
There were 4 early minor and 12 late band or weight loss related complications (Table 3). 
Seven adolescents had their band removed after 3.5±1.0 years. Two bands were removed due 
to weight loss failure and 5 due to weight regain. Two adolescents had also obstructive 
symptoms combined with weight regain. Our reoperation rate including band removals was 
42%. Two adolescents who had normal preoperative abdominal ultrasound developed 
symptomatic gall stone disease (one of which had a laparoscopic cholecystectomy 14 months 
after LAGB and the other endoscopic retrograde cholangiopancreatography and 
sphincterotomy 60 months after LAGB followed by laparoscopic cholescystectomy). There 
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were no skin removal procedures during follow up. There were no life threatening 
postoperative complications during the early and late postoperative follow up and there were 
no slippages, band erosions or pouch dilatations (Table 3). None of the adolescents had another 
bariatric surgical procedure and none of the females had an unplanned pregnancy. There were 
12 admissions to hospital related to band removals (n=7), gallstones (n=2), early postoperative 





This is the first prospective Australian study reporting on safety and medium term outcomes 
of obese adolescents who have undergone LAGB in a public health service. We have shown 
that the use of LAGB in severely obese adolescents reduced BMI by 10 kg/m2 over 45 months. 
This degree of BMI loss is comparable to previous studies and meta-analyses [9,12,16] even 
though short term BMI loss in our cohort was lower than previously reported in Australian 
adolescents participating in a randomized controlled trial over 24 months [13]. In spite of a 
lower reduction of BMI in comparison to other bariatric surgery procedures used in adolescents 
such as laparoscopic sleeve gastrectomy (LSG) or laparoscopic Roux-en-Y gastric bypass 
(LRYGB) [12], adolescents had improvement of quality of life and comorbidities without 
significant morbidity with LAGB. 
There were no major operative complications in our cohort. Life threatening surgical 
complications after LAGB in adolescents are uncommon with no reported deaths [12]. The rate 
of major complications after LAGB such as bleeding and conversion to laparotomy is 0.8% 
compared to 0.7% after LSG and 5.1% after LRYGB [12]. Even though the incidence of major  
complications such as staple leaks after LSG is low, it is of much greater significance and can 
cause severe morbidity [11,12]. There were few minor perioperative complications in our study 
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consistent with studies of bariatric surgery in adults and adolescents that showed lower minor 
perioperative complications after LAGB in comparison to LSG and LRYGB (1% compared to 
2.4% and 2.5%, respectively) [12, 20]. 
There was a higher band removal rate in our cohort compared with the few studies that have 
reported on the morbidity of LAGB beyond 3 years in adolescents [16]. In contrast, an earlier 
study from Austria including 50 adolescents reported lower band removal rate over a similar 
period of follow up [16]. The higher band removal rate in our study was most likely related to 
an aggressive practice to remove bands in case of weight loss failure/ regain with or without 
band intolerance symptoms and in keeping with our preoperative advice to use the band as an 
interim procedure .Our band removal rate is consistent with adult studies. Reasons for band 
removal after LAGB in adults are weight loss failure, intolerable obstructive symptoms or band 
related complications such as erosion,  slippage or pouch dilatation [21]. There were no band 
related complications such as erosion, slippage or pouch dilatation in our cohort.  
In addition to band removal, one late morbidity leading to reoperation in our cohort was related 
to symptomatic gall stone formation which is known to be related to weight loss and has been 
previously described in adults and adolescents [13, 22, 23].  
Our reoperation rate of 42% in the medium term follow up was not related to any severe and 
life threatening complications. Current alternatives to LAGB in adolescents are LRYGB or 
LSG. LRYGB is regarded as the golden standard by most bariatric surgeons and offers follow 
up data over 20 years [8].  Although it is a reversible procedure [24] it is malabsorptive and 
therefore requires indefinite follow up with multivitamin and calcium replacement. There is a 
significant reoperation rate and weight regain with LRYGB [25]. LSG is an irreversible 
procedure and long term data is currently not available. Furthermore there have been no 
reported deaths in adolescents post LAGB and there is less need for multivitamin 
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supplementation post LAGB compared to other procedures such as LSG or LRYGB at a 
developmental stage when adherence to medications is suboptimal.  
The strengths of the current study include the prospective single centre enrolment with a single 
paediatric bariatric surgeon and a standardized reporting method on all events post LAGB over 
a median period of 45 months. In addition, cohort maintenance was reasonable. Limitations of 
the study included limited data on other comorbidities such as obstructive sleep apnoea, 
however availability of sleep studies is limited as routine investigations for these children 
especially if they did not have symptoms. Another limitation of this study was the small sample 
size. However, long-term (beyond 36 months) results of LAGB in adolescents remain scarce 
[16]. In addition one of the largest prospective bariatric surgery studies in the U.S. (Teens LAB 
consortium) has provided 36 month follow up of only 11 adolescents post LAGB [22]. 
Even though LAGB is currently the least used bariatric surgical procedure in adults and in 
adolescents in the USA [8, 10, 22, 26], it is less invasive, it is reversible and has a lower rate 
of life threatening complications. Long term follow up beyond 5 years post LAGB in adults 
has shown an increased band removal rate due to complications [21, 27, 28]. In addition to the 
results of our study this supports the role of LAGB as a temporary management option to 
manage severe obesity during adolescence. After removal, conversion to more invasive 
bariatric procedures such as LSG or LRYGB is possible. 
 
Conclusion 
We have shown in the longest prospective post LAGB study in Australian adolescents with 
severe obesity, that LAGB improves BMI in the majority of adolescents with minimal 
complications.  LAGB may be the preferred ‘initial’ operation for adolescents with severe 
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Table 1: Individual preoperative and postoperative outcomes 



















1 Male 17.2 61.4 7.2 6 0.6 70 In situ 
2 Male 18 45.1 14.1 12 6.1 48 Removed 
3 Female 16.2 40.3 11.3 54 11.3 60 In situ 
4 Female 17.3 51.4 6.4 6 1.4 48 Removed 
5 Male 17.8 38.6 4.6 3 4.6 55 Removed 
6 Female 17.6 52.5 9.5 12 0.5 50 Removed 
7 Male 17.6 51 10 46 10 48 In situ 
8 Female 14.2 37.3 12.3 24 7.3 46 In situ 
9 Male 17.8 50 19 60 19 60 In situ 
10 Female 17.3 40.3 15.3 50 15.3 50 In situ 
11 Female 15.8 37.3 9.3 53 9.3 53 In situ 
12 Female 16.2 58.6 6.6 6 5.6 45 Removed 
13 Female 18.2 35 0.7 13 10.7 13 In situ 
14 Female 15.9 47.1 15.1 6 12.1 41 In situ 
15 Female 16.8 51.2 3.2 3 2.8 32 Removed 
16 Male 18.3 52.7 20.7 39 20.7 39 In situ 
17 Male 16.9 37.7 9.7 34 9.7 12 In situ 
18 Male 17.2 44.4 3.4 3 0.6 31 Removed 
19 Male 17.6 57.1 7.2 18 7.2 18 In situ 
20 Female 18.1 42.5 14.5 6 10.5 27 In situ 
19 
 
21 Female 17.3 62.3 16.3 28 16.3 28 In situ 
BMI, Body mass index; FU, follow up  
20 
 





3m 6m 12m 24m 36m 48m 
Available 
subjects (n) 
21 19 19 14 11 9 
Eligible 
subjects (n) 
21 21 21 21 18 14 



































































BMI, Body mass index; FU, follow up 
Data are median (interquartile range; Q1 first quartile; Q3 third quartile) 




Table 3: Early and late postoperative complications according to the Clavien - Dindo 
Classification over the follow up period 
 
Grade Complication type Less than 30 days More than 30 days 
I Haematoma 1 0 
I Food Intolerance (no 
deflation) 
2 0 
II Food intolerance 
(deflation) 
0 2 
III a Endoscopy 0 1 
III b Technical device failure 0 0 
III b Removal 0 7 
III b Slippage 0 0 
III b Erosion 0 0 
III b Infection 1 0 
III b Cholescystectomy 0 2 
III b Plastic Surgery 0 0 
IV Leak 0 0 
V Death 0 0 
 
 
 
